Abstract
Various mutations in the ‘breast cancer genes’ BRCA1 and BRCA2 increase the lifetime risks of developing breast and ovarian cancers to high levels [[1][1],[2][2]]. Because these cancers mostly develop after the cessation of reproduction—that is, after menopause—the responsible alleles may be
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Royal Society B: Biological Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
